Office of Research & Development |
![]() ![]() |
Project Number: | I01HX002714-01A2 |
Title: | Promoting benzodiazepine cessation through an electronically-delivered patient self-management intervention |
Principal Investigator: | Keith N. Humphreys |
Location: | Palo Alto, CA |
Congressional District Code: | 18 |
Research Service: | Health Services R&D |
Project Period: | September 2020 - August 2024 |
FY 2021 Funding Amount: | $194,477 |
Total Award Amount (all years): |
$1,014,028 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Background: Long-term use of benzodiazepine medication has been increasing sharply inside and outside of VA, raising the risk of cognitive decline, falls, and overdose among patients. A self-directed benzodiazepine tapering intervention known as EMPOWER was shown effective in a non-VA clinical trial, and within VA there is significant interest in tailoring it to and providing it for Veterans. Significance: Although often useful as short-term medications, when taken for extended periods benzodiaz... |